Eli Lilly Says New Drug Can Reduce Alzheimer's Disease Symptoms
byCOVID-19-
An experimental drug appears to slow cognitive and functional decline in people with Alzheimer's disease, according to a report by pharmaceutical company Eli Lilly.
An experimental drug appears to slow cognitive and functional decline in people with Alzheimer's disease, according to a report by pharmaceutical company Eli Lilly.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.